key: cord-0427086-b2srxi8z authors: Rodriguez-Maroto, G.; Atienza-Diez, I.; Ares, S.; Manrubia, S. title: Vaccination strategies in structured populations under partial immunity and reinfection date: 2021-11-24 journal: nan DOI: 10.1101/2021.11.23.21266766 sha: 19eb645d02f87675fb0094e78f4810c8c4809576 doc_id: 427086 cord_uid: b2srxi8z Optimal protocols of vaccine administration to minimize the effects of infectious diseases depend on a number of variables that admit different degrees of control. Examples include the characteristics of the disease and how it impacts on different groups of individuals as a function of sex, age or socioeconomic status, its transmission mode, or the demographic structure of the affected population. Here we introduce a compartmental model of infection propagation with vaccination and reinfection and analyse the effect that variations on the rates of these two processes have on the progression of the disease and on the number of fatalities. The population is split into two groups to highlight the overall effects on disease caused by different relationships between vaccine administration and various demographic structures. We show that optimal administration protocols depend on the vaccination rate, a variable severely conditioned by vaccine supply and acceptance. As a practical example, we study COVID-19 dynamics in various countries using real demographic data. The model can be easily applied to any other disease and demographic structure through a suitable estimation of parameter values. Simulations of the general model can be carried out at the interactive webpage https://mybinder.org/v2/gh/IkerAtienza/SIYRD/main?urlpath=%2Fvoila%2Frender%2FSimulator.ipynb Infectious diseases have profoundly shaped human habits, and societies at large [2] . 2 Their tremendous effects on morbidity and mortality could only be counteracted with 3 the advent of massive vaccination campaigns, which stand out as the most effective 4 medical interventions ever [3] . This is so despite the fact that only smallpox has been 5 eradicated (also rinderpest in animal hosts), while multiple other communicable diseases 6 persist at low incidence or with significantly milder effects in infected individuals -7 thanks to vaccination. Eradication of pathogens is difficult if they have alternative 8 species as reservoirs, in the absence of a vaccine, or if the disease is geographically 9 spread or has a complicated diagnosis. 10 Nowadays, many infectious diseases remain endemic even if a vaccine is available and 11 its administration is widespread. Vaccinated individuals can become infected because 12 vaccines only confer partial protection [4] ; if immunity wanes, both vaccinated and 13 previously infected individuals can get the infection again [5] . Around 1% of infected 14 individuals undergo reinfection by SARS-CoV-2 [6] , a percentage that is higher in the 15 case of other respiratory diseases, such as influenza, where the high variability of viral 16 strains and continued reinfections during each flu-season have made it endemic [7] . 17 Indeed, the emergence of mutant forms of pathogens that escape immune attack and 18 thus limit the protective effects of past infections or vaccination is the rule [8] , especially 19 when prevalence is high [9] . 20 The eventual fate of an emergent epidemic is uncertain as it depends on the type of 21 immunity people acquire through infection or vaccination and on how the virus 22 evolves [10] . The effects of disease in populations along typically lengthy transients 23 between the emergence of a contagious disease and its dynamical stabilization depend 24 on features of the population and of the disease, but also on controlled interventions 25 such as non-pharmaceutical measures and, critically, vaccine roll-out [11] . 26 It is hard to quantify all possible effects of vaccination [12] , since it is ideally aimed 27 at fulfilling several dissimilar goals, among others to prevent the disease and reduce its 28 severity and mortality and to minimize the impact of the disease on the health care 29 system and the economy [13] . Actually, vaccination strategies often focus on one or 30 another priority: for instance, on vaccinating first the most vulnerable groups, or on 31 starting with the individuals with the highest spreading potential, with the hope that 32 the most vulnerable group will be indirectly protected [14, 15] . Vaccination strategies 33 cannot be unique and universal [16] , since their effects vary as a function of the 34 transmission mode and severity of the specific disease, of population habits (which 35 determine contacts and therefore contagion probability), of demographic profiles and, 36 last but not least, on the availability of vaccines [17] . 37 In this contribution, we address the effect of different vaccination protocols in 38 structured populations by means of a compartmental model, and assuming a 39 non-negligible fraction of reinfections and infections of vaccinated individuals. As a 40 measure of the effects of vaccination we use the reduction in the number of deaths after 41 one year, as compared with a situation of no vaccination. The model is deliberately 42 simple to focus on the overall effects of two fixed empirical variables (the infection 43 fatality ratio, IFR, of the disease and the demographic structure of the population) and 44 one controllable variable: the vaccination rate. In the first part of the work, we explore 45 the effects of these variables in synthetic populations structured into two groups where 46 the first one has a higher number of intra-group contacts (and thus is the group that 47 best spreads the disease) and the second one contains more vulnerable individuals (with 48 a higher IFR). In the second part of the work, we apply the model to COVID-19 and 49 several different countries. In each particular case studied, we use available data on 50 demography, contact matrices between age-groups [18, 19] , and independently evaluated, 51 age-dependent IFR. Finally, we have built a public webpage [1] where multiple additional demographic profiles can be chosen and model parameters arbitrarily 53 changed, also with the goal of allowing quantitative comparison with other models in 54 the literature [14, 20] . The recovered class merges individuals from two origins: those which were infected and 61 have overcome the disease, thus bearing partial immunity to new infections, and 62 susceptible individuals which have been vaccinated. As a first approximation, we 63 assume that the degree of immunity acquired by vaccinated individuals is equivalent to 64 that of recovered individuals after natural infection. Figure 1 summarizes the transitions 65 allowed between compartments. Note that only vaccination of susceptible individuals is 66 considered, due to the assumed equivalence between vaccination and disease overcoming. 67 either through infection (to class I, at rate β SI if infected by an I individual and at rate β SY if infected by a Y individual) or vaccination (to class R, at rate v). Infected individuals may recover (R, rate r) or die (D), regardless of whether they have primary infections (I, rate µ I ) or reinfections (Y, rate µ Y ). Recovered individuals can become reinfected (by class Y at rate β RY or by class I at rate β RI ), and either recover again (to class R, rate r) or die (to class D, rate µ Y ). Green dashed lines link classes whose interaction triggers transitions. (B) As in (A), for the model with two groups. Note that transitions occur only within classes of the same group, while interactions intra-and inter-groups (green dashed lines) couple the dynamics. These interactions are weighted through contact matrices and the fraction of individuals in each group, which consider the demographic structure of the population. The equations that define the epidemic model are Parameters are rescaled in such a way that the time unit of our simulations is one 69 day. Vaccination is implemented in this model through a parameter v that represents 70 the fraction of population vaccinated per time unit, i.e. per day. This rate is multiplied 71 by a function Θ(S, θ) that takes into account its progressive slowdown and eventual halt 72 when a fraction θ of individuals has been vaccinated. The specific functional form of 73 Θ(S, θ) does not affect the overall dynamical properties of the system (see S3 Appendix). 74 The separation between primary infections (I) and reinfections (Y) entails four different 76 infection rates (see Fig. 1 Consistently, the likelihood that a susceptible individual becomes infected is larger 86 than that of a recovered individual, since the latter bears at least partial immunity 87 against the disease either due to a prior infection or to vaccination. This applies both to 88 primary infections, β SI ≥ β RI , and to reinfections, β SY ≥ β RY . Finally, we assume that 89 the ratio between the infection rates of primary-infected and reinfected individuals is 90 independent of the state of the individual that can be potentially infected, The mortality rate of primary-infected individuals can be calculated using the Finally, for simplicity we assume that the recovery rate r of primary-infected and 97 reinfected individuals is identical, neglecting possible small differences. The quantitative estimation of r depends on the IFR and on the infectious period of 99 the disease, see S2 Appendix. The vaccination rate v is a variable that can be explored 100 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.23.21266766 doi: medRxiv preprint in a range of values depending on vaccine supply. We will consider values up to 2%, 101 representing the fraction of population vaccinated in one day. A summary of parameters 102 in the SIYRD can be found in Table 1 . Table 1 . Definition of parameters in the SIYRD model. All rates have dimensions of day −1 with the exception of the vaccination rate, which has dimensions of population (fraction) × day −1 , and θ, which has dimensions of population (fraction). Parameter In order to consider the demographic structure of populations and how a given disease 105 affects different groups (e.g. depending on age or sex), we extend the SIYRD model to 106 represent two different population groups (G 1 and G 2 ) per class, each containing N 1 107 and N 2 individuals, respectively. Variables and parameters characteristic of each group 108 now get the corresponding subindex: this applies to vaccination rates v i , mortality rates 109 µ Ii and µ Yi , and recovery rates r i . Disease transmission rates β SI , β SY , β RI and β RY 110 are independent of the group to which they apply. To be consistent, the two groups are 111 connected to each other through a contact matrix that reflects individual connectivity 112 patterns (see S1 Appendix). To simplify notation, the simple, one-class model with 113 reinfection and vaccination will be called SIYRD all through the text, while the model 114 with two coupled groups will be called S 2 IYRD. 115 Equations (7-11) describe the dynamics of group G 1 in the S 2 IYRD model, This model has a second set of analogous equations, coupled to Eqs. (7) (8) (9) (10) (11) , obtained 117 by simply interchanging subindexes, 1 ↔ 2. The most important modification of the model comes from the matrix of contacts 119 M, whose elements M ij represent the number of contacts an individual of group i has 120 with individuals of group j, thus weighing the effect of intra-and inter-group contacts 121 in contagion rates (see S1 Appendix). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.23.21266766 doi: medRxiv preprint S 2 IYRD model parameters 123 Though mortality and recovery rates are in principle subject to relationships analogous 124 to those described for the SIYRD model, they can be also independently estimated for 125 each group as characteristics of the disease under consideration. Now, the values of the 126 elements M ij synthesize the contact structure of the affected population and, in general, 127 can be empirically obtained using actual demographic structure and surveys of contacts 128 between different groups in a variety of daily situations (see S1 Appendix). Finally, the 129 vaccination rate can be varied to represent different administration protocols, in order 130 to test how they affect disease progression. We will consider three situations in which 131 priority is given to G 1 , to G 2 , or both groups are simultaneously vaccinated. The result 132 of each protocol will be compared with the baseline of no vaccination. Specifically, the 133 prioritized population group is vaccinated at a rate v until the fraction of susceptible illustrating the dynamics towards different final states can be found in S3 Appendix. In 164 principle, it is not possible to determine to which steady state the system will converge 165 given the initial conditions and specific parameter values. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; In this section, we will discuss the dynamics of the S 2 IYRD model under the three 189 possible vaccination strategies: priority to G 1 , to G 2 , or simultaneous vaccination. The 190 advantage of either strategy will be evaluated under variable vaccination rates. Here, we 191 do not make explicit the criterion to split the population into two groups, and explore 192 instead the effect of these two groups having dissimilar sizes and being differently 193 affected by the disease. To this end, we will study two representative values of the 194 contact strength between groups, vary the fraction of population in either group and the 195 IFR ratio, and illustrate how these affect the optimal vaccination strategy under 196 increasing vaccination rates. Parameters can in principle be varied independently, but 197 the closure relationship M 12 n 1 = M 21 n 2 (see S1 Appendix) has to be fulfilled for 198 consistency. Also, we will restrict our explorations to cases where the group at higher 199 risk is the slower spreader; otherwise, there is no conflict between vaccinating the most 200 susceptible or the group that best spreads the disease, and the best strategy is therefore 201 trivial. Without loss of generality, group G 1 will be the faster spreader, and group G 2 202 the one most affected by the disease. We will use as measure of the effectiveness of a 203 strategy the asymptotic decrease in the number of fatalities once the epidemic halts (or, 204 alternatively, at a sufficiently long time since vaccination started). General dynamical features 206 The behavior of the model is qualitatively robust for all scenarios explored, for different 207 parameter values and contact matrices, as long as the initial reproductive number is 208 slightly above the epidemic threshold (R 0 = β SI d I 1). Nevertheless, important For sufficiently high vaccination rates (around 0.5 and higher), the reduction of deaths 231 becomes significant. Figure 3B represents the reduction obtained in number of deaths 232 for each strategy as a function of the vaccination rate and the relative group size. At 233 low vaccination rates, the advisable strategy is to vaccinate first group G 2 , the most 234 vulnerable, though the optimal strategy changes to priority given to group G 1 for 235 sufficiently high vaccination rates, the precise value of v at which the best strategy 236 November 23, 2021 8/19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.23.21266766 doi: medRxiv preprint changes depending on the relative size of the groups (see also Fig. 3C ). The selection of 237 the optimal strategy is more critical at intermediate values of the vaccination rate and 238 when the two groups have comparable sizes. At very high vaccination rates, however, 239 vaccination strategies yield similar reductions and are weakly dependent on the relative 240 group size. Figure 3D presents a quantitative summary of the effect of the best strategy. 241 Cells to the left of the thick dark red line correspond to priority to G 2 as the advisable 242 protocol, with a reduction in the number of deaths given for each vaccination rate and 243 population fraction n 2 . To the right of the thick dark red line, the optimal strategy is 244 priority vaccination of group G 1 . We have explored the effect of the IFR in the optimal vaccination strategy as a 246 function of the vaccination rate for two different group sizes (or contact matrices, recall 247 the coupling between these two quantities through the closure relation), see Figure 4 . This case serves to compare the effects of diseases of different severity (as represented by 249 the variation in the IFR) that, however, share their propagating ability and affect the 250 same population. At low IFR ratio, the strategy yielding the higher death reduction is vaccination of 252 the group with the higher number of contacts, G 1 in our examples, since both groups 253 experience similar effects of the disease. The situation is reversed as the IFR ratio 254 increases, since as the disease impinges more severely on the G 2 group, its priority 255 vaccination becomes more advantageous. As in the examples above, priority vaccination 256 of the most vulnerable group is advised for low vaccination rates. Consistently, the 257 optimal protocol changes at sufficiently high v, the threshold depending on the IFR and 258 on the difference in contacts (c.f. group sizes) between the two groups. It has been proven that age is strongly correlated with severity and mortality of 273 COVID-19 [21] [22] [23] [24] [25] [26] [27] , a disease where reinfections are not rare [28] [29] [30] . Therefore, an 274 assessment of different vaccination scenarios for SARS-CoV-2 propagation using the 275 age-stratified S 2 IYRD model appears as a useful framework to detect major qualitative 276 differences between vaccination strategies. In this section, we take different 277 demographic profiles and empirically measured COVID-19 IFRs as case-examples. Populations will be divided into two groups through an age threshold. Contact matrices 279 calculated from available data allow to estimate parameters M ij for a given population 280 split. Since there are multiple parameters that can be varied, we will discuss illustrative 281 examples in this section and leave to the interested reader to explore further cases 282 through the interactive webpage [1] that we have developed. 283 Figure 5A reports empirical data on IFR per group age for COVID-19 in Spain. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; mortality and recovery rates of primary infections (see S2 Appendix). The demographic 288 composition of the population, as in the example shown in Fig. 5B , is needed to 289 estimate the values M ij . All estimated parameters vary if the threshold age that 290 separates both groups, which affects their composition and the intra-and inter-group 291 contacts, changes (see Fig. 5C ). In the case of Spain, relative differences between the 292 two groups in IFR and number of contacts are maximized for an age threshold at 80 293 years (down-right panel in Fig. 5C ). We will keep this threshold fixed in this section to 294 focus on the relationship between demographic profiles and vaccination strategies. A 295 second case-example, with a threshold at 50 years, can be found in S4 Appendix (again, 296 different thresholds and various other countries, India, Italy and Japan at the time of 297 this writing, can be explored in the the webpage [1] ). 298 Table 2 summarizes the empirical values obtained for four different countries which 299 differ in their demographic composition and in their contacts (see S2 Appendix for raw 300 data and other details). Spain has a negative growth in recent decades that yields a 301 narrowing, cup-like demographic pyramid. It also bears the largest fraction of elder 302 population, over six-fold that of the South African Republic (SAR). Israel's 303 demographic pyramid has the Christmas-tree-like shape characteristic of young and 304 rapidly growing populations, with a fraction of population above 80 years between that 305 of Spain and the SAR. Such is the case of the elder group in the USA as well. The USA 306 demographic pyramid displays a box-like shape that reveals a population of stable size. 307 The IFR of all four countries is comparable for the elder group but differs for the young 308 one. In turn, the fraction of contacts within group G 1 is high and comparable, while 309 values of contacts between groups and within the G 2 group vary. 310 Table 2 . Empirical parameters for the countries in Fig. 6 . Updated demographic pyramids (to year 2020) and independent, empirical values of COVID-19 IFR for each country per age group have been used for these estimations. Details on data origin are reported in S1 Appendix and S2 Appendix. As previously done, we now examine three different vaccination strategies: priority 311 to the over-80-years group G 2 , priority to the younger group G 1 , and simultaneous 312 vaccination proportional to the population of either group. In the first two scenarios, 313 vaccination of the corresponding second group starts once that of the priority group 314 finishes (with a threshold θ = 0.7). Fig. 6 summarizes the effect of different vaccinating 315 protocols in the reduction of deaths as a function of the vaccination rate v for the four 316 countries above. In all cases, vaccinating first G 2 always reduces mortality more than 317 does any of the other two strategies, often more than doubling the effect of alternative 318 protocols at low vaccination rates (see Fig. 6 ). Nevertheless, the difference is minor for 319 the case of the SAR due to two main factors: the relatively high IFR of the younger 320 group and, especially, the very low size of the elder group. As a result, most deaths 321 come from G 1 , blurring the positive effect of protecting first the elder group. On the 322 other hand, the vaccination of this latter group occurs early in the monitored year and, 323 as explained, then continues with group G 1 . Therefore, its effects are not that different 324 from simultaneous vaccination (and, actually, from priority to the G 1 group) in one-year 325 time. Still, differences are observable at the initial stages of vaccination. Remarkably, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Vaccination rates, however, do make a significant quantitative difference in the 332 difference of performance between the optimal strategy and the rest. In terms of 333 reduction of fatalities, the advantage of G 1 priority barely reaches a 5% with respect to 334 the worst-performing protocol. This even requires relatively high vaccination rates 335 (around v = 1), and the improvement typically decreases with decreasing v. Increasing the vaccination rate monotonically increases the reduction in the number 337 of deaths, regardless the protocol. The increase is almost linear for Spain and Israel, but 338 accelerates with v for the SAR and the USA, especially. For example, if priority is given 339 to the group G 1 , an increase in 0.05% in the vaccination rate from v = 0.2 to 0.25 rises 340 RD in 2.3% points, while an increase from v = 0.9 to v = 0.95 causes a 4.9% increase in 341 RD. The change in RD is also about two-fold for the other two strategies. At sufficiently high vaccination rates, the three vaccination strategies reduce the 343 differences in their effect. However, even in that situation, G 2 -prioritization allows to 344 attain much earlier in time a death reduction comparable to that eventually attained 345 with any of the other two strategies, due to the early protection of the most susceptible 346 group. The goal of this work has been to analyse major effects of demographic population 349 structure, disease fatality and vaccination rate in optimal vaccination strategies in a 350 model with reinfections, and to provide a general scenario that can be applied to other 351 situations. An important variable whose effect cannot be disentangled from other 352 demographic factors is the contact between groups, which affects optimal vaccination 353 strategies through its implicit relevance in disease spread. The dynamics have been 354 evaluated using effective population-level contact matrices estimated in situations 355 without mobility restrictions [18] . Contact matrices are however a key element that 356 becomes modified in presence of an on-going pandemic due to non-pharmaceutical 357 interventions, as indirectly shown by changes in mobility [32] that directly impact 358 propagation dynamics [33] . The model incorporates other simplifications such as the 359 implementation of a limited number of compartments and the use of only two groups. Optimal vaccination roll-out depends on multiple variables. The precise value of the 361 vaccination rate at which the advantage of vaccinating first the most susceptible group 362 is lost in front of alternative strategies sensitively varies with the IFR of the specific 363 disease. At high IFR, as for COVID-19, priority vaccination to the most connected 364 group is only advantageous at remarkably high vaccination rates (above 1%, the precise 365 threshold depending on the characteristics of the population). However, the relative 366 advantage of the optimal strategy is reduced as the number of administered daily doses 367 grows. The reduction is sensitive to demographic differences in a non-trivial way: while 368 in the South African Republic and in the USA our model yields a quasi-equivalence 369 among the three different strategies for a vaccination rate v ≥ 1%, a significant 370 difference persists for Spain and Israel, for example. Our results with two age thresholds 371 (at 80 and 50 years) are consistent with the overall picture. Lowering the age threshold 372 implies a reduction of IFR in the older group and a simultaneous increase in the average 373 number of contacts per individual in both groups. In terms of death reduction, priority 374 vaccination of the older group is systematically more efficient for high IFRs (as those of 375 COVID-19). For diseases with lower IFR, as influenza, the general consensus is that 376 children should be vaccinated first due to their high transmission capacity [17, 34] . It is 377 likely that the optimal strategy for COVID-19 changes and resembles that for influenza 378 November 23, 2021 14/19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.23.21266766 doi: medRxiv preprint if the disease becomes endemic and its effects turn milder once most of the world 379 population has been either infected or vaccinated. These results are consistent with those of other model-based studies showing that 381 the optimal vaccination strategy balancing direct and indirect protection against 382 COVID-19 is highly determined by vaccine supply and efficacy [14, 35, 36] and 383 vaccination of the most susceptible group is more efficient under a broad range of 384 situations [37, 38] . Our study adds two elements to previous approaches. First, the 385 introduction of reinfections, which are non-negligible for COVID-19 and other 386 coronaviruses [5] , shows the existence of long transients (or quasi-endemic states) that 387 may predate the transition to a truly endemic state predicted for COVID-19 [11] . 388 Second, the model is simple enough so as to allow the characterization of systematic 389 effects due to, at least, group size, demographic composition and IFRs. As other models used to inform optimal vaccination roll-out [14, [35] [36] [37] , our model 391 assumes that individuals within a given group have on average the same number of 392 contacts. More realistic models should consider heterogeneity in the number of contacts, 393 since it has been shown that highly skewed contact distributions, with hubs (or, 394 equivalent from a dynamic viewpoint, super-spreader individuals or events) have 395 important effects in immunity thresholds [39] and in vaccination strategies. For 396 example, the convenience of vaccinating network hubs first has been broadly 397 discussed [40, 41] , though that strategy is hampered by the difficulty of identifying 398 actual hubs with local information. An interesting alternative consists in vaccinating 399 neighbors of randomly chosen individuals, since these neighbors have more contacts on 400 average [42] . Still, this latter strategy cannot consider protective behaviors exhibited by 401 individuals, which might be independent of their contact habits. Perhaps an improved 402 strategy should include at once a sensible use of this last strategy coupled with 403 individual-dependent IFR, a quantity that depends not only on age, but also on sex, 404 comorbidities and social roles, among others. Regardless the details of the model, the 405 most efficient immunization strategy is conditioned by the availability of vaccines at 406 each time, and optimization is particularly critical when availability is low-to-medium, 407 while different strategies converge at sufficiently high vaccination rates. 408 We have focused in the reduction in the number of fatalities under different 409 vaccination protocols, since this is a short-term benefit that can be easily quantified. 410 However, different vaccination protocols also affect hospital occupation or the number of 411 infections, and the variation can be very large depending on population structure, 412 contact habits, and vaccination rate. The benefits of reducing the number of infections 413 are more difficult to evaluate, but have to be kept in mind as our knowledge of the 414 adaptive strategies of SARS-CoV-2 improves: more infections entail an enhanced 415 number of circulating viral variants and therefore a higher probability of emergence of 416 strains able to escape the protective effect of vaccines. In the mid and long term, it 417 might be advisable to seek optimal vaccination strategies that simultaneously minimize 418 the number of fatalities and the number of infections. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.23.21266766 doi: medRxiv preprint S 2 IYRD Model Simulator Epidemics and Society Proceedings of the National Academy of Sciences of the United States of America Heterogeneity and longevity of antibody memory to viruses and vaccines Direct Observation of Repeated Infections With Endemic Coronaviruses Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. The Lancet Seasonal coronavirus protective immunity is short-lasting Viral evolution and Immune responses Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination The coronavirus will become endemic Immunological characteristics govern the transition of COVID-19 to endemicity Valuing vaccination Impact of Vaccines; Health, Economic and Social Perspectives Model-informed COVID-19 vaccine prioritization strategies by age and serostatus COVID-19 vaccination rate and protection attitudes can determine the best prioritisation strategy to reduce fatalities Optimizing age-specific vaccination Optimizing Influenza Vaccine Distribution Inferring high-resolution human mixing patterns for disease modeling for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group C, et al. Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community Age-dependent effects in the transmission and control of COVID-19 epidemics Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China Why does COVID-19 disproportionately affect older people? Aging Association between age and clinical characteristics and outcomes of COVID-19 Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020 Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Genomic evidence for reinfection with SARS-CoV-2: a case study. The Lancet Infectious Diseases Use of "normal" risk to improve understanding of dangers of COVID-19 Public Mobility Data Enables COVID-19 Forecasting and Management at Local and Global Scales Impacts of social distancing policies on mobility and COVID-19 case growth in the US Population-wide benefits of routine vaccination of children against influenza COVID-19 vaccination rate and protection attitudes can determine the best prioritisation strategy to reduce fatalities Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity Modelling optimal vaccination strategy for SARS-CoV-2 in the UK Vaccine optimization for COVID-19, who to vaccinate first? Science Advances Epidemic Spreading in Scale-Free Networks Immunization of Complex Networks. Physical review E, Statistical, nonlinear, and soft matter physics Physical review E, Statistical, nonlinear, and soft matter physics Efficient Immunization Strategies for Computer Networks and Populations. Physical review letters The authors are indebted to A. Vespignani for support with the use of their data.